Search Results

Displaying Results 5301-5325 of 13488 "'TEL'"

Jun 03, 2026, 01:00 ET WIN EURASIA 2026 to Showcase the Future of Manufacturing

https://mma.prnewswire.com/media/2993315/WIN_EURASIA_Logo.jpgContact: Nalan Kahraman, [email protected], Tel. +90 5413454105

More news about: WIN EURASIA


Jun 03, 2026, 01:00 ET WIN EURASIA 2026 to Showcase the Future of Manufacturing

https://mma.prnewswire.com/media/2993315/WIN_EURASIA_Logo.jpgContact: Nalan Kahraman, [email protected], Tel. +90 5413454105

More news about: WIN EURASIA


Jun 03, 2026, 00:37 ET Another vote of confidence from international: Bank Leumi Completes Overseas CoCo Bond Issuance totaling USD 1 Billion - in the lowest spread in the history of an Israeli bank issuance ‎

TEL AVIV, Israel, June 3, 2026 /PRNewswire/ -- Bank Leumi (TASE: LUMI) announced today that it has successfully completed an international issuance of CoCo bonds from a range of institutional investors abroad and in Israel,

More news about: Bank Leumi


Jun 03, 2026, 00:19 ET Rosen Law Firm Encourages Wise Group plc Investors to Inquire About Securities Class Action Investigation - WSE

Esq.     Phillip Kim, Esq.     The Rosen Law Firm, P.A.     275 Madison Avenue, 40th Floor     New York, NY 10016     Tel: (212) 686-1060     Toll Free: (866) 767-3653     Fax: (212) 202-3827     

More news about: THE ROSEN LAW FIRM, P. A.


Jun 03, 2026, 00:16 ET Rosen Law Firm Encourages Futu Holdings Limited Investors to Inquire About Securities Class Action Investigation - FUTU

Esq.     Phillip Kim, Esq.     The Rosen Law Firm, P.A.     275 Madison Avenue, 40th Floor     New York, NY 10016     Tel: (212) 686-1060     Toll Free: (866) 767-3653     Fax: (212) 202-3827     

More news about: THE ROSEN LAW FIRM, P. A.


Jun 03, 2026, 00:14 ET Rosen Law Firm Encourages UP Fintech Holding Limited Investors to Inquire About Securities Class Action Investigation - TIGR

Esq.     Phillip Kim, Esq.     The Rosen Law Firm, P.A.     275 Madison Avenue, 40th Floor     New York, NY 10016     Tel: (212) 686-1060     Toll Free: (866) 767-3653     Fax: (212) 202-3827     

More news about: THE ROSEN LAW FIRM, P. A.


Jun 02, 2026, 21:20 ET Abivax Investigation Initiated: SueWallSt Investigates the Officers and Directors of Abivax (ABVX)

Street, 27th FloorNew York, NY [email protected]Tel: (888) SueWallStFax: (212) 363-7171

More news about: SueWallSt.com


Jun 02, 2026, 20:02 ET Regencell Deadline: RGC Investors with Losses in Excess of $100K Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit

Esq.     Phillip Kim, Esq.     The Rosen Law Firm, P.A.     275 Madison Avenue, 40th Floor     New York, NY 10016     Tel: (212) 686-1060     Toll Free: (866) 767-3653     Fax: (212) 202-3827     

More news about: THE ROSEN LAW FIRM, P. A.


Jun 02, 2026, 19:42 ET FSK Investors Have Opportunity to Lead FS KKR Capital Corp. Securities Fraud Lawsuit

Esq.     Phillip Kim, Esq.     The Rosen Law Firm, P.A.     275 Madison Avenue, 40th Floor     New York, NY 10016     Tel: (212) 686-1060     Toll Free: (866) 767-3653     Fax: (212) 202-3827     

More news about: THE ROSEN LAW FIRM, P. A.


Jun 02, 2026, 18:59 ET Rosen Law Firm Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG

Information:Laurence Rosen, Esq.Phillip Kim, Esq.The Rosen Law Firm, P.A.275 Madison Avenue, 40th FloorNew York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) [email protected]

More news about: THE ROSEN LAW FIRM, P. A.


Jun 02, 2026, 18:58 ET UPST Deadline: UPST Investors with Losses in Excess of $100K Have Opportunity to Lead Upstart Holdings, Inc. Securities Fraud Lawsuit

Information:Laurence Rosen, Esq.Phillip Kim, Esq.The Rosen Law Firm, P.A.275 Madison Avenue, 40th FloorNew York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) [email protected]

More news about: THE ROSEN LAW FIRM, P. A.


Jun 02, 2026, 16:58 ET Fulcrum Therapeutics, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Fulcrum Therapeutics, Inc. (FULC)

Street, 27th Floor New York, NY 10004 [email protected] Tel: (212) 363-7500 Fax: (212) 363-7171 View

More news about: Levi & Korsinsky, LLP


Jun 02, 2026, 15:30 ET Rosen Law Firm Encourages Zillow Group, Inc. Investors to Inquire About Securities Class Action Investigation - Z, ZG

Esq.     Phillip Kim, Esq.     The Rosen Law Firm, P.A.     275 Madison Avenue, 40th Floor     New York, NY 10016     Tel: (212) 686-1060     Toll Free: (866) 767-3653     Fax: (212) 202-3827     

More news about: THE ROSEN LAW FIRM, P. A.


Jun 02, 2026, 15:30 ET Skyhawk Therapeutics annonce les résultats intermédiaires à douze mois de l'essai clinique de phases 1/2 de SKY-0515 dans le traitement de la maladie de Huntington

les personnes vivant avec la maladie de Huntington dans le monde entier, pour lesquelles un traitement oral abaissant le taux de protéine huntingtine, tel que SKY-0515, changera véritablement la donne. »« Les résultats annoncés aujourd'hui de l'essai de phases 1/2 en cours de SKY-0515, incluant maintenant

More news about: Skyhawk Therapeutics


Jun 02, 2026, 15:04 ET Polar, ein Unternehmen im Portfolio von H.I.G. Capital, schließt eine rekordverdächtige Anleiheemission in den nordischen Ländern im Umfang von 800 Millionen Euro ab

[email protected]. Capital10 Grosvenor Street2nd FloorLondon W1K 4QBVereinigtes KönigreichTel.: +44 (0) 207 318 5700

More news about: H.I.G. Capital


Jun 02, 2026, 15:01 ET Polar, une société du portefeuille de H.I.G. Capital, finalise une émission obligataire record de 800 millions EUR sur le marché nordique

[email protected]. Capital10 Grosvenor Street2nd FloorLondon W1K 4QBRoyaume-UniTél. : +44 (0) 207 318 5700

More news about: H.I.G. Capital


Jun 02, 2026, 12:20 ET Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Sleep Number Corporation (NASDAQ: SNBR)

[email protected] or [email protected]Tel: (800) 575-0735 or (212) 545-4774This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and

More news about: Wolf Haldenstein Adler Freeman & Herz LLP


Jun 02, 2026, 12:04 ET Changingtek Robotics lanza Uhand, una mano de recolección de datos táctiles de alta precisión

tecnologías avanzadas de efectores finales robóticos.Información de contacto:Changingtek Robotics Technology (Suzhou) Co., Ltd.Tel: +86 512 5323 3370 / +86 158 7124 2390WhatsApp: +86 158 7124 2390Email: [email protected]ágina

More news about: Changingtek Robotics Technology (suzhou) Co., Ltd.


Jun 02, 2026, 12:00 ET Changingtek Robotics bringt Uhand auf den Markt, eine hochpräzise Hand zur Erfassung taktiler Sensordaten

fortschrittlicher Technologien für Roboter-Endeffektoren weiter voran.Kontakt:Changingtek Robotics Technology (Suzhou) Co., Ltd.Tel: +86 512 5323 3370 / +86 158 7124 2390WhatsApp: +86 158 7124 2390E-Mail: [email protected]:

More news about: Changingtek Robotics Technology (suzhou) Co., Ltd.


Jun 02, 2026, 11:55 ET Changingtek Robotics lance Uhand, une main de collecte de données à détection tactile de haute précision

technologies avancées d'effecteurs terminaux robotiques.Coordonnées :Changingtek Robotics Technology (Suzhou) Co., Ltd.Tél. : +86 512 5323 3370 / +86 158 7124 2390WhatsApp : +86 158 7124 2390Courriel : [email protected] :

More news about: Changingtek Robotics Technology (suzhou) Co., Ltd.


Jun 02, 2026, 11:15 ET Milestone gathers 400 Security Leaders to help shape the future of AI and Video Intelligence

ContactSophie CederstrømSenior PR [email protected]Tel: +45 50 84 29 55

More news about: Milestone Systems


Jun 02, 2026, 11:08 ET Law Firm Cohn & Dussi Expands Collections and Legal Support into Canada

cohnanddussi.com.MEDIA CONTACT:Lisa LazarczykLAZ PRTel: 617.838.7327 or [email protected]

More news about: Cohn & Dussi


Jun 02, 2026, 10:02 ET Karyopharm's Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis Selected for Late-Breaking Oral Presentation at EHA 2026

endometrial cancer.For more information about Karyopharm's products or clinical trials, please contact the Medical Information department at: Tel: +1 (888) 209-9326; Email: [email protected]®

More news about: Karyopharm Therapeutics Inc.


Jun 02, 2026, 09:00 ET Hypercore Announces Technology Integration with Arcesium for Comprehensive Private Credit Lifecycle Management

integration transforms private credit with an AI-powered operating layer, connecting loans to fund-level intelligence TEL AVIV, Israel, June 2, 2026 /PRNewswire/ -- 

More news about: Hypercore


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.